Further in vivo functional experiments demonstrated that substituting endogenous PGK1 with a mitochondrial translocation-deficient mutant, PGK1 S203A, inhibited cancer cell proliferation and induced apoptosis [81]. The gene discussed is PGK1; the disease is cancer.